IDH1andIDH2Mutations in Gliomas
Author(s) -
Hai Yan,
D. Williams Parsons,
Genglin Jin,
Roger E. McLendon,
B. Ahmed Rasheed,
Weishi Yuan,
Ivan Kos,
Ines Batinic̈Haberle,
Siân Jones,
Gregory J. Riggins,
Henry S. Friedman,
Allan H. Friedman,
David A. Reardon,
James E. Herndon,
Kenneth W. Kinzler,
Victor E. Velculescu,
Bert Vogelstein,
Darell D. Bigner
Publication year - 2009
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0808710
Subject(s) - idh2 , idh1 , isocitrate dehydrogenase , glioma , gene , mutation , somatic cell , cancer research , mutant , biology , genetics , enzyme , biochemistry
A recent genomewide mutational analysis of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower-grade gliomas (secondary glioblastomas).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom